NEPH
Price
$4.00
Change
+$0.17 (+4.44%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
42.4M
58 days until earnings call
STRRP
Price
$9.68
Change
+$0.38 (+4.09%)
Updated
Sep 8, 03:23 PM (EDT)
Capitalization
N/A
Interact to see
Advertisement

NEPH vs STRRP

Header iconNEPH vs STRRP Comparison
Open Charts NEPH vs STRRPBanner chart's image
Nephros
Price$4.00
Change+$0.17 (+4.44%)
Volume$100
Capitalization42.4M
Star Equity Holdings
Price$9.68
Change+$0.38 (+4.09%)
Volume$100
CapitalizationN/A
NEPH vs STRRP Comparison Chart in %
Loading...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRRP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEPH vs. STRRP commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEPH is a StrongBuy and STRRP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (NEPH: $3.93 vs. STRRP: $9.68)
Brand notoriety: NEPH and STRRP are both not notable
NEPH represents the Pharmaceuticals: Other, while STRRP is part of the Other Consumer Services industry
Current volume relative to the 65-day Moving Average: NEPH: 124% vs. STRRP: 173%
Market capitalization -- NEPH: $42.4M vs. STRRP: $0
NEPH [@Pharmaceuticals: Other] is valued at $42.4M. STRRP’s [@Other Consumer Services] market capitalization is $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.48B to $0. The market cap for tickers in the [@Other Consumer Services] industry ranges from $78.56B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.16B. The average market capitalization across the [@Other Consumer Services] industry is $1.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEPH’s FA Score shows that 0 FA rating(s) are green whileSTRRP’s FA Score has 1 green FA rating(s).

  • NEPH’s FA Score: 0 green, 5 red.
  • STRRP’s FA Score: 1 green, 4 red.
According to our system of comparison, NEPH is a better buy in the long-term than STRRP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEPH’s TA Score shows that 5 TA indicator(s) are bullish while STRRP’s TA Score has 8 bullish TA indicator(s).

  • NEPH’s TA Score: 5 bullish, 5 bearish.
  • STRRP’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, STRRP is a better buy in the short-term than NEPH.

Price Growth

NEPH (@Pharmaceuticals: Other) experienced а +5.36% price change this week, while STRRP (@Other Consumer Services) price change was +5.79% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.90%. For the same industry, the average monthly price growth was +4.93%, and the average quarterly price growth was +24.89%.

The average weekly price growth across all stocks in the @Other Consumer Services industry was -4.84%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was -2.34%.

Reported Earning Dates

NEPH is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.90% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Other Consumer Services (-4.84% weekly)

Other consumer services include companies that provide consumer services, and are not classified elsewhere. Travel fare aggregators, hotel bookings, consumer-to-consumer or business-to-business sales platforms are some examples of services that can be clubbed into this category. Many of such services have expanded online. Booking Holdings Inc, The Priceline Group Inc, and eBay Inc. are some major operators in this segment.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEPH YTD gains are higher at: 160.544 vs. STRRP (4.260). NEPH has higher annual earnings (EBITDA): 1.49M vs. STRRP (-1.31M). STRRP has more cash in the bank: 16.8M vs. NEPH (5.07M). STRRP has less debt than NEPH: STRRP (971K) vs NEPH (1.24M). STRRP has higher revenues than NEPH: STRRP (138M) vs NEPH (16.7M).
NEPHSTRRPNEPH / STRRP
Capitalization42.4MN/A-
EBITDA1.49M-1.31M-114%
Gain YTD160.5444.2603,769%
P/E Ratio33.33N/A-
Revenue16.7M138M12%
Total Cash5.07M16.8M30%
Total Debt1.24M971K128%
FUNDAMENTALS RATINGS
NEPH vs STRRP: Fundamental Ratings
NEPH
STRRP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
10081
SMR RATING
1..100
54100
PRICE GROWTH RATING
1..100
3656
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STRRP's Valuation (3) in the null industry is somewhat better than the same rating for NEPH (66). This means that STRRP’s stock grew somewhat faster than NEPH’s over the last 12 months.

STRRP's Profit vs Risk Rating (81) in the null industry is in the same range as NEPH (100). This means that STRRP’s stock grew similarly to NEPH’s over the last 12 months.

NEPH's SMR Rating (54) in the null industry is somewhat better than the same rating for STRRP (100). This means that NEPH’s stock grew somewhat faster than STRRP’s over the last 12 months.

NEPH's Price Growth Rating (36) in the null industry is in the same range as STRRP (56). This means that NEPH’s stock grew similarly to STRRP’s over the last 12 months.

NEPH's P/E Growth Rating (100) in the null industry is in the same range as STRRP (100). This means that NEPH’s stock grew similarly to STRRP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEPHSTRRP
RSI
ODDS (%)
Bearish Trend 5 days ago
76%
Bearish Trend 5 days ago
50%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
73%
Bullish Trend 5 days ago
54%
Momentum
ODDS (%)
Bearish Trend 5 days ago
81%
Bearish Trend 5 days ago
47%
MACD
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 5 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
42%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 5 days ago
38%
Advances
ODDS (%)
Bullish Trend 16 days ago
75%
Bullish Trend 21 days ago
51%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
N/A
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
79%
Bearish Trend 5 days ago
40%
Aroon
ODDS (%)
Bearish Trend 5 days ago
84%
Bullish Trend 5 days ago
50%
View a ticker or compare two or three
Interact to see
Advertisement
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRRP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HALO74.931.53
+2.08%
Halozyme Therapeutics
ATMCU12.65N/A
N/A
AlphaTime Acquisition Corp
WINA479.66-0.03
-0.01%
Winmark Corp
KPTI6.60-0.14
-2.00%
Karyopharm Therapeutics Inc.
SPOK17.44-0.67
-3.70%
Spok Holdings

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with IMDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then IMDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
-4.13%
IMDX - NEPH
34%
Loosely correlated
+0.40%
SGHT - NEPH
33%
Loosely correlated
-1.07%
NEO - NEPH
25%
Poorly correlated
-0.99%
OFIX - NEPH
22%
Poorly correlated
-1.02%
VNRX - NEPH
22%
Poorly correlated
-5.18%
More

STRRP and

Correlation & Price change

A.I.dvisor tells us that STRRP and POAI have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STRRP and POAI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRRP
1D Price
Change %
STRRP100%
N/A
POAI - STRRP
29%
Poorly correlated
-1.13%
PROF - STRRP
21%
Poorly correlated
-6.79%
NSYS - STRRP
21%
Poorly correlated
+1.31%
NEPH - STRRP
20%
Poorly correlated
-4.13%
VMD - STRRP
20%
Poorly correlated
+0.88%
More